Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Europe and UK: Price negotiations and national reimbursement frameworks often push prices down substantially, in some markets to a small fraction of US list prices
Even with these coverage limits on obesity drugs in place, utilization and gross spending on GLP-1 drugs for approved uses in Medicare and Medicaid have increased considerably in recent years
The FDA recently issued warnings about compounders creating diabetes and weight loss injectables with impermissible starting ingredients
Women going through menopause typically experience a drop in bone density, increasing the risk of osteoporosis and bone fractures
Across multiple SURPASS trials, tirzepatide demonstrated A1C reductions ranging from 1.9% to 2.4% from baseline A1C levels of approximately 8.0%, depending on the dose
Finding the Right Fitness Partner for Your Practice Supplementing GLP-1 treatment with exercise can help patients see the results they desire, which in turn may increase their satisfaction with their treatment plan
